Lanean...
Do we still need breast cancer screening in the era of targeted therapies and precision medicine?
Breast cancer (BC) is the most common female cancer and the second cause of death among women worldwide. The 5-year relative survival rate recently improved up to 90% due to increased population coverage and women’s attendance to organised mammography screening as well as to advances in therapies, e...
Gorde:
| Argitaratua izan da: | Insights Imaging |
|---|---|
| Egile Nagusiak: | , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
Springer Berlin Heidelberg
2020
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7519022/ https://ncbi.nlm.nih.gov/pubmed/32975658 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13244-020-00905-3 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|